Perrigo Company plc provided earnings guidance for the year 2022. For the period, the company expects net sales growth of 3.5% to 4.5%, inclusive of negative impacts of approximately 2.0% points from the planned divestiture of the Latin American businesses and 1.5% points from adverse currency movements. Net sales of $170 million - $190 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
31.46 USD | +2.14% | +0.51% | -2.24% |
Mar. 19 | Sector Update: Health Care Stocks Rise Late Afternoon | MT |
Mar. 19 | Sector Update: Health Care Stocks Higher in Tuesday Afternoon Trading | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.24% | 4.26B | |
+33.50% | 701B | |
+26.24% | 571B | |
+0.78% | 381B | |
+20.85% | 334B | |
+16.38% | 319B | |
+2.69% | 210B | |
+0.96% | 210B | |
-6.61% | 201B | |
-3.51% | 157B |
- Stock
- Equities
- Stock Perrigo Company plc - Nyse
- News Perrigo Company plc
- Perrigo Company plc Provides Earnings Guidance for the Year 2022